Chronic and Latent Viral Infections and Leukocyte Telomere Length across the Lifespan of Female and Male Individuals Living with or without HIV.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
10 May 2024
Historique:
received: 05 04 2024
revised: 01 05 2024
accepted: 01 05 2024
medline: 25 5 2024
pubmed: 25 5 2024
entrez: 25 5 2024
Statut: epublish

Résumé

Chronic/latent viral infections may accelerate immunological aging, particularly among people living with HIV (PLWH). We characterized chronic/latent virus infections across their lifespan and investigated their associations with leukocyte telomere length (LTL). Participants enrolled in the CARMA cohort study were randomly selected to include n = 15 for each decade of age between 0 and >60 y, for each sex, and each HIV status. Cytomegalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus 8 (HHV-8), herpes simplex virus 1 (HSV-1), and HSV-2 infection were determined serologically; HIV, hepatitis C (HCV), and hepatitis B (HBV) were self-reported. LTLs were measured using monochrome multiplex qPCR. Associations between the number of viruses, LTL, and sociodemographic factors were assessed using ordinal logistic and linear regression modeling. The study included 187 PLWH (105 female/82 male) and 190 HIV-negative participants (105 female/84 male), ranging in age from 0.7 to 76.1 years. Living with HIV, being older, and being female were associated with harbouring a greater number of chronic/latent non-HIV viruses. Having more infections was in turn bivariately associated with a shorter LTL. In multivariable analyses, older age, living with HIV, and the female sex remained independently associated with having more infections, while having 3-4 viruses (vs. 0-2) was associated with a shorter LTL. Our results suggest that persistent viral infections are more prevalent in PLWH and females, and that these may contribute to immunological aging. Whether this is associated with comorbidities later in life remains an important question.

Sections du résumé

BACKGROUND BACKGROUND
Chronic/latent viral infections may accelerate immunological aging, particularly among people living with HIV (PLWH). We characterized chronic/latent virus infections across their lifespan and investigated their associations with leukocyte telomere length (LTL).
METHODS METHODS
Participants enrolled in the CARMA cohort study were randomly selected to include n = 15 for each decade of age between 0 and >60 y, for each sex, and each HIV status. Cytomegalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus 8 (HHV-8), herpes simplex virus 1 (HSV-1), and HSV-2 infection were determined serologically; HIV, hepatitis C (HCV), and hepatitis B (HBV) were self-reported. LTLs were measured using monochrome multiplex qPCR. Associations between the number of viruses, LTL, and sociodemographic factors were assessed using ordinal logistic and linear regression modeling.
RESULTS RESULTS
The study included 187 PLWH (105 female/82 male) and 190 HIV-negative participants (105 female/84 male), ranging in age from 0.7 to 76.1 years. Living with HIV, being older, and being female were associated with harbouring a greater number of chronic/latent non-HIV viruses. Having more infections was in turn bivariately associated with a shorter LTL. In multivariable analyses, older age, living with HIV, and the female sex remained independently associated with having more infections, while having 3-4 viruses (vs. 0-2) was associated with a shorter LTL.
CONCLUSIONS CONCLUSIONS
Our results suggest that persistent viral infections are more prevalent in PLWH and females, and that these may contribute to immunological aging. Whether this is associated with comorbidities later in life remains an important question.

Identifiants

pubmed: 38793637
pii: v16050755
doi: 10.3390/v16050755
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : HET-85515
Pays : Canada
Organisme : Canadian Institutes of Health Researc
ID : TCO-125269
Organisme : CIHR
ID : GER-163053
Pays : Canada

Auteurs

Nancy Yi Yang (NY)

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
Centre for Blood Research, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.

Anthony Y Y Hsieh (AYY)

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
Centre for Blood Research, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.

Zhuo Chen (Z)

Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC V6T 2A1, Canada.

Amber R Campbell (AR)

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
Women's Health Research Institute, British Columbia Women's Hospital and Health Centre, Vancouver, BC V6H 2N9, Canada.
Oak Tree Clinic, BC Women's Hospital and Health Centre, Vancouver, BC V5Z 0C9, Canada.

Izabella Gadawska (I)

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.

Fatima Kakkar (F)

Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.

Laura Sauve (L)

Women's Health Research Institute, British Columbia Women's Hospital and Health Centre, Vancouver, BC V6H 2N9, Canada.
Oak Tree Clinic, BC Women's Hospital and Health Centre, Vancouver, BC V5Z 0C9, Canada.
Department of Pediatrics, University of British Columbia, Vancouver, BC V6H 3V4, Canada.

Ari Bitnun (A)

Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada.

Jason Brophy (J)

Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON K1H 8L1, Canada.

Melanie C M Murray (MCM)

Women's Health Research Institute, British Columbia Women's Hospital and Health Centre, Vancouver, BC V6H 2N9, Canada.
Oak Tree Clinic, BC Women's Hospital and Health Centre, Vancouver, BC V5Z 0C9, Canada.
Department of Medicine, Division of Infectious Diseases, University of British Columbia Faculty of Medicine, Vancouver, BC V5Z 1M9, Canada.

Neora Pick (N)

Women's Health Research Institute, British Columbia Women's Hospital and Health Centre, Vancouver, BC V6H 2N9, Canada.
Oak Tree Clinic, BC Women's Hospital and Health Centre, Vancouver, BC V5Z 0C9, Canada.
Department of Medicine, Division of Infectious Diseases, University of British Columbia Faculty of Medicine, Vancouver, BC V5Z 1M9, Canada.

Mel Krajden (M)

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
British Columbia Center for Disease Control, Vancouver, BC V5Z 4R4, Canada.

Hélène C F Côté (HCF)

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
Centre for Blood Research, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Women's Health Research Institute, British Columbia Women's Hospital and Health Centre, Vancouver, BC V6H 2N9, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH